Multiple Sclerosis Center

Dr. Dorfman has served as director of Stanford's MS Center for more than 25 years and is the medical director of the Stanford Neurodiagnostic Labs. He is past president of the American Association for Neuromuscular and Electrodiagnostic Medicine, and of the Association of California Neurologists, and he served on the clinical advisory board of the Silicon Valley Chapter of the National MS Society. He has published more than 50 scholarly papers on topics in neurology and neurophysiology. Dr. Dorfman received his medical training at Albert Einstein College of Medicine in New York, his neurology residency at Stanford and his fellowship training in clinical neurophysiology at the National Hospital for Neurological Diseases in London and at the Mayo Clinic.

Dr. Dunn is a board certified neurologist specializing in the diagnosis, treatment and clinical research of multiple sclerosis and demyelinating disease. With a focus on clinical care, he also conducts research on combination therapy and emerging immunotherapy and has worked as a principal investigator for clinical research studies sponsored by the NIH and other organizations. Dr. Dunn served as president and chief medical officer of the "MS Hub," a novel regional care center at Evergreen Healthcare in Kirkland, WA, before joining the MS Center at Stanford in early 2008. He has been recognized as one of the nation's "top docs" for the last eight consecutive years. Dr, Dunn earned his MD from Temple University and did his specialty training in neurology at the University of Washington.

Dr. Steinman's research focuses on what provokes relapses and remissions in MS and the nature of the genes that serve as a brake on brain inflammation in his quest for a vaccine against multiple sclerosis. He has taken several therapies from the bench to the bedside, including work directly related to the development of natalizumab, and two experimental therapies, statins and DNA vaccines, are in trials. Dr. Steinman founded two biotech companies, Neurocrine Biosciences and Bayhill Therapeutics, and served on the board of directors at Centocor. He received the John M. Dystel Prize in 2004 and has twice been awarded a Javits Neuroscience Award for his work. A graduate of Harvard School of Medicine, Dr. Steinman has been on the Stanford faculty since 1980.

Dr. Han is a Clinician-Scientist whose research focuses on identification of biomarkers and therapeutic targets in Multiple Sclerosis and demyelinating diseases. She utilizes Systems Biology approach such as proteomics and transcriptomics. She received her medical degree in Myanmar and completed Neurology residency at University of Washington in Seattle. She did a Translational Fellowship in Neuroimmunology at Stanford with Dr. Steinman. She joined the Neurology department and MS Center in 2009.

Joined the Multiple Sclerosis Team June 2008. Previously worked as staff nurse on B3, Neurosurgical Unit at Stanford Hospital and Clinics. Graduated from University of California at Berkeley with Bachelors of Arts in Legal Studies. Graduated with Masters of Science in Nursing in Family Nurse Practitioner program at Samuel Merritt College.